COMPUGEN LTD
Data quality: 100%
CGEN
Nasdaq
Manufacturing
Chemicals
$2.46
▲
$0.17
(7.21%)
Mkt Cap: 233.15 M
Price
$2.46
Mkt Cap
233.15 M
Day Range
$2.28 — $2.49
52-Week Range
$1.15 — $2.49
Volume
339,338
Open $2.31
50D / 200D Avg
$1.97
24.78% above
50D / 200D Avg
$1.70
44.49% above
Quick Summary
Key Takeaways
Revenue grew 86.61% annually over 5 years — strong growth
ROE of 65.09% indicates high profitability
Net margin of 48.57% shows strong profitability
Generating 31.33 M in free cash flow
P/E of 6.60 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 74.53%
Growth
Revenue Growth (5Y)
86.61%
Above sector avg (9.35%)
Revenue (1Y)161.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
65.09%
Above sector avg (-51.02%)
ROIC36.51%
Net Margin48.57%
Op. Margin43.05%
Safety
Debt / Equity
N/A
Current Ratio4.74
Interest Coverage1118.79
Valuation
PE (TTM)
6.60
Above sector avg (-1.98)
P/B Ratio4.64
EV/EBITDA7.24
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 6.6 | -2.0 |
| P/B | 4.6 | 5.1 |
| ROE % | 65.1 | -51.0 |
| Net Margin % | 48.6 | -150.2 |
| Rev Growth 5Y % | 86.6 | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 161.14% | Revenue Growth (3Y) | 47.47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 86.61% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 72.76 M | Net Income (TTM) | 35.34 M |
| ROE | 65.09% | ROA | 32.62% |
| Gross Margin | 87.29% | Operating Margin | 43.05% |
| Net Margin | 48.57% | Free Cash Flow (TTM) | 31.33 M |
| ROIC | 36.51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.74 |
| Interest Coverage | 1118.79 | Asset Turnover | 0.67 |
| Working Capital | 77.06 M | Tangible Book Value | 50.26 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 6.60 | Forward P/E | N/A |
| P/B Ratio | 4.64 | P/S Ratio | 3.20 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 7.24 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 13.44% | ||
| Market Cap | 233.15 M | Enterprise Value | 226.68 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.38 | Revenue / Share | 0.77 |
| FCF / Share | 0.33 | OCF / Share | 0.33 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.42% | FCF Conversion | 88.64% |
| SBC-Adj. FCF | 24.74 M | Growth Momentum | 74.53 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 72.76 M | 27.86 M | 33.46 M | 7.50 M | 6.00 M |
| Net Income | 35.34 M | -14.23 M | -18.75 M | -33.69 M | -34.20 M |
| EPS (Diluted) | 0.38 | -0.16 | -0.21 | -0.39 | -0.41 |
| Gross Profit | 63.51 M | 19.93 M | 31.46 M | 6.53 M | 5.32 M |
| Operating Income | 31.33 M | -14.89 M | -12.99 M | -35.37 M | -35.07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 22.76 M | 24.81 M | 34.47 M | 30.65 M | 28.69 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 28,000.0 | 34,000.0 | 31,000.0 | 27,000.0 | 25,000.0 |
| Income Tax | 54,000.0 | 4.52 M | 8.97 M | 58,000.0 | -722,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 156.57 M | 115.00 M | 121.33 M | 94.18 M | 132.16 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | 102.73 M | 54.91 M | 65.56 M | 77.68 M | 106.69 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 90.60 M | 18.23 M | 13.89 M | 11.06 M | 7.80 M |
| Current Assets | 148.02 M | 106.00 M | 114.58 M | 86.13 M | 123.22 M |
| Current Liabilities | 22.57 M | 20.16 M | 26.27 M | 11.92 M | 17.10 M |
{"event":"ticker_viewed","properties":{"ticker":"CGEN","listing_kind":"stock","pathname":"/stocks/cgen","exchange":"Nasdaq","country":"US"}}